BB-102

N/A

Report date: 2025/11/22 20:00:09
NME

Base Information

Drug NameBB-102
Drug Alias NameBB-102BB102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 inhibitors
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsSolid tumoursCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBroadenbio Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBroadenbio Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A